Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sivaramakrishna Rachakonda

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Cancers|March 4, 2020
Telomeres and Telomere Length: A General OverviewNalini Srinivas, Sivaramakrishna Rachakonda, Rajiv Kumar
International Journal of Cancer|July 27, 2021
Occurrence, functionality and abundance of the TERT promoter mutationsSivaramakrishna Rachakonda, Jörg D Hoheisel, Rajiv Kumar
Current Opinion in Genetics & Development|March 25, 2014
TERT promoter mutations in cancer developmentBarbara Heidenreich, P Sivaramakrishna Rachakonda, Kari Hemminki, et al.
Arthritis and Rheumatism|June 26, 2008
Application of inflammation-responsive promoter for an in vitro arthritis modelP Sivaramakrishna Rachakonda, Muhammad Farooq Rai, Michael F G Schmidt
European Biophysics Journal : EBJ|January 11, 2007
Conformational change of influenza virus hemagglutinin is sensitive to ionic concentrationThomas Korte, Kai Ludwig, Qiang Huang, et al.
Proteins|July 12, 2008
Energetics of the loop-to-helix transition leading to the coiled-coil structure of influenza virus hemagglutinin HA2 subunitsQiang Huang, Thomas Korte, P Sivaramakrishna Rachakonda, et al.
Cytokine|March 2, 2010
Co-expression of insulin-like growth factor-1 and interleukin-4 in an in vitro inflammatory modelKizzie Manning, P Sivaramakrishna Rachakonda, Muhammad Farooq Rai, et al.
Cytokine|September 16, 2008
Expression of canine interleukin-4 in canine chondrocytes inhibits inflammatory cascade through STAT6P Sivaramakrishna Rachakonda, Muhammad F Rai, Kizzie Manning, et al.
Hereditary Cancer in Clinical Practice|August 8, 2020
Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an exampleKari Hemminki, Aayushi Srivastava, Sivaramakrishna Rachakonda, et al.
Oncotarget|March 24, 2015
TERT promoter mutations and telomere length in adult malignant gliomas and recurrencesBarbara Heidenreich, P Sivaramakrishna Rachakonda, Ismail Hosen, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Cancers|March 4, 2020
Telomeres and Telomere Length: A General OverviewNalini Srinivas, Sivaramakrishna Rachakonda, Rajiv Kumar
International Journal of Cancer|July 27, 2021
Occurrence, functionality and abundance of the TERT promoter mutationsSivaramakrishna Rachakonda, Jörg D Hoheisel, Rajiv Kumar
Current Opinion in Genetics & Development|March 25, 2014
TERT promoter mutations in cancer developmentBarbara Heidenreich, P Sivaramakrishna Rachakonda, Kari Hemminki, et al.
Arthritis and Rheumatism|June 26, 2008
Application of inflammation-responsive promoter for an in vitro arthritis modelP Sivaramakrishna Rachakonda, Muhammad Farooq Rai, Michael F G Schmidt
European Biophysics Journal : EBJ|January 11, 2007
Conformational change of influenza virus hemagglutinin is sensitive to ionic concentrationThomas Korte, Kai Ludwig, Qiang Huang, et al.
Proteins|July 12, 2008
Energetics of the loop-to-helix transition leading to the coiled-coil structure of influenza virus hemagglutinin HA2 subunitsQiang Huang, Thomas Korte, P Sivaramakrishna Rachakonda, et al.
Cytokine|March 2, 2010
Co-expression of insulin-like growth factor-1 and interleukin-4 in an in vitro inflammatory modelKizzie Manning, P Sivaramakrishna Rachakonda, Muhammad Farooq Rai, et al.
Cytokine|September 16, 2008
Expression of canine interleukin-4 in canine chondrocytes inhibits inflammatory cascade through STAT6P Sivaramakrishna Rachakonda, Muhammad F Rai, Kizzie Manning, et al.
Hereditary Cancer in Clinical Practice|August 8, 2020
Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an exampleKari Hemminki, Aayushi Srivastava, Sivaramakrishna Rachakonda, et al.
Oncotarget|March 24, 2015
TERT promoter mutations and telomere length in adult malignant gliomas and recurrencesBarbara Heidenreich, P Sivaramakrishna Rachakonda, Ismail Hosen, et al.
Pageof 6